Search Results 521-530 of 16963 for monoclonal antibody
In late 2024, the FDA also approved the use of a new monoclonal antibody drug that uses a lab-made protein that binds to a specific target on a cancer cell to ...
Monoclonal antibodies, such as rituximab, may block cancer growth in different ways by targeting certain cells. Romidepsin and lenalidomide may stop the ...
Tumors with high number of mutations may respond well to immunotherapy. Immunotherapy with monoclonal antibodies such as ipilimumab and nivolumab may help the ...
Cancer treatment myths: Any truth to these common beliefs? Monoclonal antibody drugs for cancer: How they work · Cancer survival rate: What it means for your ...
Bezlotoxumab, a monoclonal antibody against toxin B was recently approved by the Food and Drug Administration for treatment of CDI in patients at high risk ...
Veltuzumab (humanized anti-CD20 monoclonal antibody): characterization, current clinical results, and future prospects. Goldenberg DM. David M; Morschhauser ...
Monoclonal antibodies, such as bevacizumab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find ...
Monoclonal antibodies, such as cetuximab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find ...
You received convalescent plasma or monoclonal antibody in the last 90 days. Health care providers stress that getting vaccinated for COVID-19 is an ...
Although the prognosis for such patients is generally poor, the use of humanized monoclonal anti-HER2 antibodies, such as trastuzumab, has resulted in long ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can be doubled in impact thanks to a $100,000 Summer Challenge.